Cargando…
Precision Oncology—The Quest for Evidence
The molecular characterization of patient tumors provides a rational and highly promising approach for guiding oncologists in treatment decision-making. Notwithstanding, genomic medicine still remains in its infancy, with innovators and early adopters continuing to carry a significant portion of the...
Autores principales: | Soldatos, Theodoros G., Kaduthanam, Sajo, Jackson, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789813/ https://www.ncbi.nlm.nih.gov/pubmed/31492009 http://dx.doi.org/10.3390/jpm9030043 |
Ejemplares similares
-
Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
por: Hirotsu, Yosuke, et al.
Publicado: (2020) -
Quest for precision in simulations for the LHC
por: Krauss, Frank Martin
Publicado: (2016) -
Adverse Event Circumstances and the Case of Drug Interactions
por: Soldatos, Theodoros G., et al.
Publicado: (2019) -
Quest for cardiovascular interventions: precise modeling and 3D printing of heart valves
por: Vashistha, Rajat, et al.
Publicado: (2019) -
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
por: Soldatos, Theodoros G., et al.
Publicado: (2022)